Compositions for the treatment of parkinson's disease...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4427 (2006.01) A61K 31/135 (2006.01) A61K 31/198 (2006.01) A61K 31/277 (2006.01) A61K 31/397 (2006.01) A61K 31/4045 (2006.01) A61K 31/428 (2006.01) A61K 31/4985 (2006.01) A61P 25/16 (2006.01)

Patent

CA 2458348

The invention relates to the association of one or more CB1 antagonist azetidine derivatives and one or more products that activate dopaminergic neurotransmission in the brain, the pharmaceutical compositions containing same and the use thereof for the treatment of Parkinson's disease.

La présente invention concerne l'association d'un ou de plusieurs dérivés d'azétidine antagonistes CB1 et d'un ou de plusieurs produits qui activent la neurotransmission dopaminergique dans le cerveau, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de Parkinson.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions for the treatment of parkinson's disease... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for the treatment of parkinson's disease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the treatment of parkinson's disease... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1991300

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.